Fighting the Swamp and Conflicts of Interest, Truth About DOGE Cuts, and Finding Autism Cause, with FDA Commissioner Dr. Marty Makary | Ep. 1051

Speaker 2 Across the country, classrooms are in crisis. Students are showing up, ready to learn, but their schools don't even have funding for even the most basic supplies.

Speaker 2 On Donors Choose, you can change that. Your donation puts books, art supplies, and student smiles into the classrooms that need the most.
Tis the season for action. Choose students.

Speaker 2 Make a difference today. Donate now at donorschoose.org slash local.

Speaker 3 Hey, weirdos.

Speaker 4 I'm Elena and I'm Ash and we are the hosts of Morbid Podcast.

Speaker 3 Each week, we dive into the dark and fascinating world of true crime, spooky history, and the unexplained.

Speaker 4 From infamous killers and unsolved mysteries to haunted places and strange legends, we cover it all with research, empathy, humor, and a few creative expletives.

Speaker 3 It's smart, it's spooky, and it's just the right amount of weird.

Speaker 4 Two new episodes drop every week, and there's even a bonus once a month.

Speaker 3 Find us wherever you listen to podcasts.

Speaker 5 Yay! Woo!

Speaker 2 Welcome to the Megan Kelly Show, live on Sirius XM channel 111 every weekday at Moon East.

Speaker 2 Hey everyone, I'm Megan Kelly. Welcome to the Megan Kelly Show and we are at the FDA today speaking with the new commissioner, Dr.
Marty McCary.

Speaker 2 I gotta tell you, it was freaky walking into this building because they've been so demonized.

Speaker 2 They've demonized themselves over the whole COVID regime and the craziness of the past five years to walk into here and like look around and like these are some of the people who participated in this is sort of eerie.

Speaker 2 But the good news is there's a new sheriff in town and Dr. Marty McCary is the real deal.
He's a surgeon, scientist, has devoted his life to public health. He's the son of a doctor.
He's a doctor.

Speaker 2 He's at the Johns Hopkins Hospital. He was performing surgery right up to the day he went in and started this job the day before.

Speaker 2 So he's had a lifelong interest in medicine and in public health more generally, and has been very honest about things that are controversial, like COVID, and was an early seer.

Speaker 2 on the things that the medical establishment was doing wrong and was totally fearless in speaking out against it with absolutely nothing to gain and actually a lot to lose.

Speaker 2 And that is how he became one of the trusted voices along with Dr. Jay Bhattacharya of Stanford, who's running NIH.

Speaker 2 And of course, then there's Bobby Kennedy, not a doctor, but a lawyer, who is atop them all as he runs HHS.

Speaker 1 So this is Dr.

Speaker 2 McCary's first interview as FDA commissioner, and there was a lot to cover.

Speaker 2 Like, how is he going to deal with the people here who can't stand any of the men I just mentioned, not to mention President Trump.

Speaker 2 And how are we going to actually start enacting the Maha agenda that Kennedy and Trump and others have been pushing and talking about for so long when it comes to our food, never mind our drugs?

Speaker 2 There's a lot to go over, including the corruption that has gone on here for a long time with the revolving door of people.

Speaker 2 Working here, approving drugs, and then immediately going to work at those drug companies. Working here and working with Big Pharma as they together decide whether the latest drug should be approved.

Speaker 2 He's all over it. We get into all of it.
Enjoy.

Speaker 2 Grand Canyon University, a private Christian university in beautiful Phoenix, Arizona, believes that we are endowed by our creator with certain unalienable rights to life, liberty, and the pursuit of happiness.

Speaker 2 GCU believes in equal opportunity and that the American dream starts with purpose. By honoring your career calling, you can impact your family, friends, and your community.

Speaker 2 Change the world for good by putting others before yourself.

Speaker 2 Whether your pursuit involves a bachelor's, master's, or doctoral degree, GCU's online, on-campus, and hybrid learning environments are designed to help you achieve your unique academic, personal, and professional goals.

Speaker 2 There's the NCAA tournament, which they are in again this year. With over 340 academic programs as of September of 24, GCU meets you where you are and provides a path to help you fulfill your dreams.

Speaker 2 The pursuit to serve others is yours. Let it flourish.
Find your purpose at Grand Canyon University, private, Christian, affordable. Visit gcu.edu.

Speaker 2 Commissioner.

Speaker 1 Megan Kelly, great to see you.

Speaker 2 I mean, you were just on my set and you were just doctor. And now look at you.
You could have stayed in the private sector, kept rolling in pretty good money.

Speaker 2 And you decided to take this job, which is an amazing thing for America. But why?

Speaker 1 Well, welcome to the FDA, Megan. It's great to have you out here.

Speaker 1 You know, we are not on a good path as a country in terms of the health outcomes of the population.

Speaker 1 We do great with sophisticated operations and amazing drugs that can treat certain kinds of lymphoma and other types of cures. But when it comes to the health of the population right now,

Speaker 1 we have had this massive area that we're not talking about that we need to be talking about, and that is the rise of all these chronic diseases.

Speaker 1 We've got one in six women now affected with autoimmune diseases. Half of kids are sick.
Pre-diabetes affects about 20% of teens. 70% of kids are not qualifying for the military.

Speaker 1 So we've got to start talking about our problems and not just keep throwing medications at them.

Speaker 2 Causes and not just possible cures, which often don't turn out to be anything of the sort. So

Speaker 2 let me start here. You've been here 17 days.

Speaker 1 Day 17 today.

Speaker 2 All right. So what are the biggest things that you've learned so far? What's jumped out at you as a civilian who now suddenly is in government service?

Speaker 1 Well, I got to be honest with you, I had a lot of emotions the last day I was in the operating room, the day before my Senate confirmation hearing. And so it's an entirely different world here.

Speaker 1 I am on a listening tour. We're talking to the career scientists.
We're trying to make sure they have all the resources they need to do their job well.

Speaker 1 We're trying to change the culture here to make it more of a teamwork culture. It's been very siloed.

Speaker 1 Each of the centers has developed their own fiefdom with their own communications department and lawyers and lobbyists for Congress and IT departments. And the IT systems don't talk.

Speaker 1 They're on different systems. So that's why you have, you know, VAIRs and FAIRs and CARES and 10 different adverse event reporting systems.
We probably need one really good one.

Speaker 1 So I'm doing an inventory right now, trying to assess the lay of the land.

Speaker 2 And then we're also trying to change the culture to a culture of teamwork, the scientific gold standard and common sense working together and that is our goal right now in medicine in general there's this divide a push-pull right now between sort of the old school doctors and the new functional medicine doctors the new maha push and there's some resistance between the two i don't have to tell you that Are you seeing any of that reflected here?

Speaker 2 Do you think the folks here are open-minded to Maha and functional medicine and doing things a different way?

Speaker 1 We need both. We need, you know, as somebody who is a highly sub-specialized pancreatic specialist,

Speaker 1 we need people who think broadly and think functionally and think about the fact that 90% of type 2 diabetes is curable by changing what you eat. Changing what you eat can actually

Speaker 1 take care of a certain type of rash that somebody develops. almost as good as some of these expensive biologics in certain circumstances.
So we need people who think differently.

Speaker 1 We need fresh new ideas. We need the old guard to ensure that we hold to rigorous scientific methodology.
And we need fresh new ideas at the same time.

Speaker 1 So we're trying to bring all of that together now. And people have forgotten that the FDA stands for food.
And so that is a major focus with Secretary Kennedy and this administration. Right.

Speaker 2 We're always so focused on the D, especially on the heels of COVID.

Speaker 2 And we think of the FDA, most of us, especially on the right, poorly, because we feel like we were railroaded and doing things we didn't want to do.

Speaker 2 And especially, you know, before COVID, there was the opioid crisis and the FDA's role in that. So it has a bad rap, I think, generally, with many in the country.
So how do you turn that around?

Speaker 1 Well, I mean, we're still reeling back from some of the disastrous healthcare corruption that the government was involved in. The food pyramid, one of the greatest pieces of misinformation.

Speaker 1 put out there that has informed school lunch programs, that has informed what people define as healthy. And so we now have a group that's reevaluating the nutrition guidance.

Speaker 1 We have a Maha Commission that is going to be putting out a massive report that doesn't just talk about calories in, calories out.

Speaker 1 It talks about food ingredients and chemicals that don't appear in nature that are going down the GI tracks of our nation's children every day nonstop. And it may not be one ingredient.

Speaker 1 that is driving some of these chronic diseases. It may not be one ingredient involved in attention deficit disorder.
It may be the cumulative burden of all of it.

Speaker 1 So we are now taking a much wider view. And you mentioned the opioid issue.

Speaker 1 That probably is the quintessential example of what's wrong with a cozy relationship when the regulator agency is captured by the industry.

Speaker 1 The person who literally authorized OxyContin then went to work for Purdue Farmer COVID. Exactly.

Speaker 2 He worked here. He authorized OxyContin.
He approved a label that suggested it wasn't really that addictive, if at all.

Speaker 1 And then after he left here, he went to work for Purdue Pharma, another company he helped. Sweetheart deal.
And

Speaker 1 that label was illegal, in my opinion.

Speaker 1 It was an indication for chronic pain, for round-the-clock,

Speaker 1 long-term use. And it was based on a 14-day study.
And so that kind of mistake can result in a million Americans losing their lives.

Speaker 1 And when you don't have good post-approval monitoring, as this agency has not had, you discover things decades later.

Speaker 1 We discovered Vioxx killed maybe 38,000 plus Americans years after it was approved. We discovered a million Americans died of opioids and overdoses.

Speaker 1 over a decade after the OxyContin label was given. Why weren't we monitoring in real time people who were getting it immediately after approval?

Speaker 1 In part, the answer to that question is we couldn't do it. We didn't have the data.
It was too sophisticated. You'd have to have everybody registered in a study.

Speaker 1 Now we have giant big data from electronic health records nationally.

Speaker 1 Now we can have our researchers and universities go in there and look at everyone who's taken a new medication, match to somebody who's similar who is not taking that medication, and look at the adverse event rate and ask, is it working?

Speaker 1 Is there a safety signal? When you don't do that, people get suspicious and they are suspicious about the cozy relationship sometimes that results in approvals.

Speaker 1 And they're also suspicious when they hear stories and they don't have hard data. You don't have great rates about certain complications when you just have self-reported data.

Speaker 1 Self-reported data is terrible data.

Speaker 2 Yeah, it could be any like, how do you know if my sleepless night was due to the COVID vaccine or I'm stressed out?

Speaker 1 That's right. And in the void of good scientific data, every opinion fills that void.
So we can do a better job.

Speaker 1 And if we have good post-approval monitoring of drugs and devices, then we can also tell companies, hey, instead of doing two randomized control trials to get your drug on the market, how about one?

Speaker 1 And we'll take a close look in the post-approval monitoring, how the drug is doing in real time immediately after it's approved.

Speaker 1 And that's particularly important when you're talking about rare diseases. When you talk about a genetic

Speaker 1 issue that affects 52 kids in the world, and that's a real thing. There is a condition that affects 52, or 15 kids.
That's also a real thing.

Speaker 1 You can't expect the companies to do a randomized control trial. You'll kill innovation.
You'll kill investment in those innovative ideas. You've got to say,

Speaker 1 Hey, this is a very difficult condition. It's incurable.
It's fatal. It's a permanent disability.
We're going to customize the approval process to the condition.

Speaker 1 And so we're going to be rolling out a new pathway for drugs, which is a pathway based on a plausible mechanism.

Speaker 1 If there's a rare condition or a condition that's incurable, that affects a small number of people, we may be approving drugs based on a plausible mechanism on sort of a conditional basis.

Speaker 1 What does that mean?

Speaker 2 Put that in normal speak.

Speaker 1 Let's say there's a condition that affects 75 people in the world, and there's a new treatment that makes sense physiologically.

Speaker 1 The mechanism is scientifically plausible that this treatment would help these individuals. No one's forcing these medications on these individuals.

Speaker 1 If they want to try these new medications, even though we don't have a randomized control trial, because it's not feasible, we will allow that.

Speaker 1 And at the same time, monitor everybody who gets it so that we can make inferences as soon as the data speaks with a signal in the data. Wow.

Speaker 2 I like the sound of that.

Speaker 2 One of the questions I had when you were going over like vaccine, VARES, which is the vaccine website where you go to upload your negative consequences, people know it from COVID, is

Speaker 2 aren't those things only as good as the people who monitor them? Because you and I have talked before, we talked throughout COVID with doctors like Minet Prasad, who's a big fan of yours.

Speaker 2 about the myocarditis that we were seeing, especially in young teenage boys, as a result of the vaccine, especially the second shot, and then the boosters.

Speaker 2 And those things were being uploaded to VARES, but we weren't getting red alert warnings from the FDA. And so this is one of the reasons people don't trust the FDA.
Like there's an agenda.

Speaker 2 They don't want to tell us about this negative side effect because they're much more concerned with forcing us to take the shot.

Speaker 1 There's been, look, there's, let's be honest, there's been an epidemic of distrust and part of it is warranted.

Speaker 1 And when you don't want to look at complications, the complication rate looks lower than it really is. And and it makes products look safer than they really are.
And so in the case of VARES,

Speaker 1 you have something that could suggest, it's a screening tool. It could suggest that there's an issue, but you have to do a rigorous evaluation.

Speaker 1 If you don't follow up with a rigorous evaluation, that screening tool is not very useful.

Speaker 2 Or if you don't want to know.

Speaker 1 Exactly.

Speaker 2 But aren't the same people all here who didn't want to know when it was your predecessor and it was the Biden administration?

Speaker 1 We're going to know. We're going to do intense comprehensive research.

Speaker 1 And that's why if we have massive electronic health record data, which we now have through something called the Health Information Exchange, we can have researchers go into there and look at real-world complication rates.

Speaker 1 So we're not relying on self-reported data. from which you can make no inferences about rates.
That's just a basic scientific methodologic principle.

Speaker 1 When you have a couple people saying, hey, I had this or I had this, you can't infer what the rate is, that is the frequency per unit time.

Speaker 1 But when you have comprehensive data, which we only have now because of cloud storage ability, we couldn't do this 10 years ago.

Speaker 1 We have now tremendous big data where we can go in there and look at, here's 100,000 people who took this product.

Speaker 1 Let's follow them in the data de-identified to protect privacy and look at how many people came back to the hospital.

Speaker 1 Not just came back to the hospital with myocarditis coded, but who came into a clinic and said, my chest hurts. That,

Speaker 1 once you have good methodologic capture of outcomes, now you're looking at real rates.

Speaker 2 Will that happen? Because since Kennedy took over, and FDA is under Kennedy at HHS, people should know.

Speaker 2 When he took over, a guy named Peter Marks, who was here, it's FDA's former top vaccine regulator. Well, he was forced out reportedly that you approved it.
And then Kennedy said, okay, good.

Speaker 1 I'm fine.

Speaker 2 Get rid of him.

Speaker 2 And in his resignation letters, his forced resignation reportedly, he said, it's become clear that truth and transparency are not desired by the Secretary, but rather he wishes subservient confirmation of his misinformation and lies.

Speaker 2 He accused Secretary Kennedy of undermining confidence in well-established vaccines.

Speaker 2 And then he accused Secretary Kennedy of wanting to access and directly edit VAIRES, which the FDA oversees, saying, we don't trust them. He used an expletive.

Speaker 2 They would write over the data or erase the whole whole database. So I don't know what he's suggesting here, that Secretary Kennedy would go into VARES.

Speaker 2 It seems to me it'd be more like the people who are pushing the vaccines on us, who would go into the VARES database and erase things.

Speaker 2 But you tell me whether Secretary Kennedy and you should have access to VARES and actually start figuring out whether, I mean, there are still parents who are getting their teenage boys the third, the fourth shot of the COVID vaccine, not knowing about the myocarditis.

Speaker 1 Yeah, I mean, if if you follow the guidelines as they've been written to the to the exact letter, a 12-year-old healthy, thin girl should be on her eighth COVID vaccine mRNA booster shot.

Speaker 1 And so Secretary Kennedy has called for gold standard science. And I can tell you, and Dr.

Speaker 1 Bhattachari will tell you the same thing at the NIH, is he has posed questions, but he is not engaging in the details of how real garret scientific methodology should be conducted.

Speaker 1 He's posing questions as is most of America right now. Again, I don't think VARES is a good database because it is self-reported and not rates.

Speaker 1 On Peter Marks, I can tell you that

Speaker 1 I never knew the guy. I never met him.
He resigned before I came to office.

Speaker 1 Some people liked some of the things he did and some people had concerns with some of the things he did.

Speaker 1 One of the biggest concerns, of course, was that he pushed out the two top scientific vaccine experts here at the FDA. And this all came out in a House judiciary hearing last summer.

Speaker 1 The two top vaccine experts at the FDA were pushed out by Peter Marx. It's not an opinion.
It's in the congressional hearing.

Speaker 2 And as I recall, they were objecting to certain things that seemed arbitrary, like mandates for children, vaccines for six-year-olds, that kind of thing.

Speaker 1 Exactly. They had concerns, according to their testimony, they had concerns over the COVID mRNA booster repeat strategy as a mandate in children.

Speaker 1 And as you know, some people have said, it makes no sense. We don't have good data on the risk benefit profile.
The two top vaccine career scientists at the FDA, Dr. Gruber and Dr.

Speaker 1 Krauss, head director and deputy director of the vaccine research center here at the FDA, were forced out by Dr. Marks.

Speaker 1 you know sometimes you have to block out some of the noise where now he's taking a you know a different view.

Speaker 1 I never met the guy, but that's, those are the different ideas people have on Peter Right. There's a lot of talented people who can do that job well.

Speaker 1 A lot of very smart people who are right now who are applying for that job.

Speaker 2 My guess in knowing you is you want people who welcome that kind of questioning. Let's have more questions.
Let's search that up. Let's let's run that down.

Speaker 2 Not somebody who, like we've had, shuts down any questioning that doesn't toe the party line.

Speaker 1 We are not going to be shutting down ideas, ideas that may be different from my ideas. We should welcome that.

Speaker 1 Science is based on challenging deeply held assumptions where there's no good evidence, what we call medical dogma. That is the scientific process.
And so we shouldn't be shutting down other ideas.

Speaker 1 We should be inviting them. And that's why we're going to be having roundtable expert panels, FDA expert panels on menopause and hormone replacement therapy on a whole host of topics.

Speaker 2 Sorry about that. I'm queuing up a clip because I want to jump back to some reforms you're starting with.

Speaker 2 And one of the big issues we touched on a minute ago, people like Curtis Wright, he's not the only one to leave the FDA and go right into big pharma. Almost every commissioner does.

Speaker 2 Scott Gottlieb, he was under Trump. He was the FDA commissioner, went right off to Pfizer.

Speaker 2 He came on my show and tried to tell me nothing to worry about with any side effects as he's working for Pfizer. It's like, we know we can't trust these people.
So,

Speaker 2 A, what are we going to do about those people?

Speaker 2 And B,

Speaker 2 is there anything else we need to worry about? Because it's not just people who are at FDA and leave.

Speaker 2 It's also panels of big pharma representatives who oversee the process as a drug gets approved here at FDA. Those are my two questions.
Let me key it. I'm going to show you this clip here.

Speaker 6 So when Curtis Wright approved the original FDA label, was there an internal pushback? Oh, yeah.

Speaker 7 Diane Snitchler emailed him that Purdue's less addictive claim sounded like bullshit.

Speaker 1 What was Mr. Wright's response?

Speaker 7 He said, actually Diane, this is literally true.

Speaker 6 So Curtis Wright is the FDA medical review officer who approves an unprecedented label for Purdue and then he goes and works for Purdue.

Speaker 6 So do you think there's quid pro quo with Purdue to grant such generous wording?

Speaker 8 Yeah, well I get that it has the appearance of corruption, but it's possible there wasn't. What Curtis Wright did

Speaker 8 is the way the industry works.

Speaker 8 It's a revolving fork, where as soon as people leave the government, they go and work for the exact people they were regulating for five times the money. And it's all legal.

Speaker 7 What appears to be corruption is simply how the system works.

Speaker 2 Simply how the system works. So

Speaker 2 is that,

Speaker 1 what, if anything, is being done about that?

Speaker 1 Well, we have to do two things. Number one we have to partner with industry and pharma to facilitate the process to make it user-friendly and expeditious.
We shouldn't be in a receive-only mode.

Speaker 1 We want American pharma companies to do well and companies that do business in the United States to do well. But the scientific evaluation needs to be independent.

Speaker 1 And that's why today we're announcing we are removing industry members, pharma members from FDA advisory committees.

Speaker 1 I was shocked when I learned that employees of big pharma companies sit on FDA advisory committees as members of those committees.

Speaker 1 So we're going to be replacing them whenever statutorily possible with patients and family givers, family caregivers.

Speaker 1 We are going to be inviting pharma companies to send representatives to the advisory committees, but they can sit with the rest of the public and watch and pose questions as the rest of the American public can.

Speaker 2 So that speaks to,

Speaker 2 it doesn't stop at FDAers leaving and going directly to Big Pharma to work pushing the drugs they just approved while government employees.

Speaker 2 It's also while the FDA is approving those drugs, Big Pharma right now has a role in pushing for it, in advising the people who are the decision makers.

Speaker 2 And so on that second piece of it, at least, right now, you're stopping that.

Speaker 1 We're stopping that for every committee where we can by statute, and we're replacing them with with patients and family caregivers. And the idea is that

Speaker 1 there should not be a cozy relationship. There should be a user-friendly process for industry, but not a cozy relationship.

Speaker 1 Because let's be honest, a lot of people in the United States feel that the system is rigged. A lot of people feel that the relationship is too cozy between pharma and regulators.
And so

Speaker 1 this is an agency that belongs to the American people. And so we can work with pharma and at the same time ensure that scientific evaluation process is totally independent.

Speaker 1 And on those advisory committees, the pharma and device members of those advisory committees will say that they're non-voting members. But that is a sort of a close club.

Speaker 1 of individuals that has a running dialogue and they meet and they become

Speaker 1 they become friendly. And it's okay to be friendly, but we need the scientific evaluation, the voting to be totally independent.
And so people ask,

Speaker 1 are you anti-pharma or pro-pharma? And the reality is we're pro-pharma, but our evaluation has to be independent.

Speaker 1 And we cannot have any more indications for chronic pain written for a drug based on a 14-day study where the regulator then goes immediately works for the company.

Speaker 1 That's the kind of thing that breeds distrust. And that's why people perceive that this agency, the FDA, has been captured by industry.
And it is not captured by industry.

Speaker 1 It is owned by the American people right now.

Speaker 2 How do we stop the first problem with all the FDA commissioners and the top head honchos doing their stint in government service and then going out to work for big pharma like they did in the Purdue Pharma case with Curtis Wright and making five times more?

Speaker 1 I don't know. We live in a free country.
I do know some of these individuals and they are good people and I have, they're all God's children. They're doing what the market incentivizes.

Speaker 1 But when it comes to their influence on the operations of the FDA, that is something that we cannot tolerate. We cannot have people who leave as regulators go to the industry.

Speaker 1 And we've thought about an ethics pledge. We've thought about all kinds of things.
It's non-binding because we live in a free country. You can't control someone after they leave an employer.

Speaker 1 But what we can do is create a culture here where people want to stay. We can ensure that people who leave don't have undue influence.
And so, many of the former.

Speaker 2 I have a suggestion for you. Yeah.

Speaker 2 If somebody leaves the FDA and goes to work for one of the drug companies, then you should look back to see whether they were involved in approving any of that company's drugs during their tenure over the previous five years.

Speaker 2 And it should kick in an automatic review on that drug and the approval.

Speaker 1 When I got this nomination for the job, I cannot tell you how many lobbyists, former

Speaker 1 members of congress the

Speaker 1 swamp reached out to me this is the swamp i mean i i was in the operating room and the next day i discovered what the swamp you were swampy

Speaker 1 surrounded by the swamp creatures surrounded by the swamp creatures and immediately it this is how it happens we want to help you with your confirmation we want to write a letter on behalf of our company to the senators on your committee.

Speaker 1 We know these senators. We're going to talk to them if it's okay with you.
And you know what I said? Don't talk to the senators. I don't want your letters.
They're not for free.

Speaker 1 Those are obligations that then you feel indebted to return once you're in office. And I'd rather not get confirmed into this job than have those obligations.
Right on.

Speaker 2 And you were confirmed. You're the only Trump nominee that's had as many Democrats cross over to support you.
You've gotten more than anybody, I think. Was it 56, 44?

Speaker 1 Yes. There literally should be nothing political about the FDA.
We're talking about values.

Speaker 1 Look, Republican, Democrat, independent moms came out and voted for President Trump, and they believed in Secretary Kennedy's Maha Mish.

Speaker 1 There's literally nothing political about looking at the influence of food colors and ingredients and evaluating the grass standard and getting infant formula without seed oil and added sugar and rewriting our nutrition guidelines, which we're doing right now.

Speaker 1 These are the most apolitical things in society. Of course, you're going to have media try to spin things, of course, but I think people see through that.

Speaker 2 On the food,

Speaker 2 my daughter turned 14 this past Monday, and I was baking her a cake. And I went, I mean, I just got the Duncan Heinz.
I'm not going to lie. I can't do anything from scratch.

Speaker 2 But then I just took a moment to look at what was in the icing, you know, with what you would use to write happy birthday.

Speaker 2 Everything in there was red dye, number this, yellow dye, number that, green dye, number this. And I thought, this is...
this could alternatively read carcinogen X,

Speaker 2 carcinogen Y.

Speaker 2 And that's where I drew the line.

Speaker 2 I'm sure there were tons of seed oils and so on in the cake itself. But my point is, how does that even make its way onto the shelf?

Speaker 2 Where the vast majority of people have no idea that all those dyes that are in our food, but not in the Europeans, can cause cancer.

Speaker 2 And so I'm giving my child cancer for her 14th birthday, which is a no.

Speaker 1 What I don't understand is if there's enough preliminary data to suggest that there may be carcinogenic effects or genomic disruption or associations with attention deficit disorder or a whole plethora of families that are saying, hey, once we started eliminating these food, petrochemical food colorings from the food of my child, their behavior improved.

Speaker 1 When you have enough of that, it's not...

Speaker 1 Look, they're not giant randomized control studies over 10 years for each food dye. We're not going to get that.

Speaker 1 But when you have enough preliminary data to suggest these petrochemical food dyes are concerning who then would conclude ah you know what let's just risk it it's fine we'll wing it we'll be you know the kids will prop maybe fine with why why do that right when we have all of these chronic diseases increasing right in front of our eyes that were rare a generation ago one in 22 boys in California now has autism.

Speaker 1 I mean, when you have to see these statistics, who says, you know what, it might be some of these ingredients have been suggested. Europe doesn't have them.
They don't need them.

Speaker 1 The food prices are not higher because they use beet juice and carrot juice and watermelon juice. I know you had Vonnie Hari on.
She's a great champion for that.

Speaker 1 We're taking a close look at this, and I think you're going to hear some action in the coming weeks on this.

Speaker 2 Before we go to the autism, then because Kennedy made news on that too, on the drugs, it's fun to demonize drug companies because we're all kind of ticked off, I think, about the COVID vaccines and so on.

Speaker 2 Not all, but many of us.

Speaker 1 However,

Speaker 2 they're not all bad. They do make some drugs that have helped a lot of people.
America's drunk on Ozempic.

Speaker 2 But I mean, like, there are some actual, you know, serious drugs that can help people.

Speaker 2 And so one of the concerns behind people who back big pharma is how much is all of this, some of the stuff we're talking about, going to slow down the approval process for new drugs or drugs and testing?

Speaker 1 We're speeding up the approval process. We made an announcement last week that we are reducing the requirements for some profunctory things, like animal testing.

Speaker 1 Why are we testing every single drug in chimpanzees and dogs, usually beagles, because they're obedient? That's so sad. It's sad and it's unnecessary.

Speaker 1 Some of these drugs are already proved in other countries, in humans. So you have a drug already in use in humans in other countries and we're requiring animal testing before.

Speaker 1 So we are now, we've put out a release that we are now taking steps to reduce the animal testing requirement. It's cruel to the animals sometimes.
It's unnecessary.

Speaker 1 And we live in a modern world where we have computational modeling using AI that can evaluate a molecule and predict its toxicity in humans better than the animal testing.

Speaker 1 We also have something called organ on a chip technology, where say liver cells are grown in the lab.

Speaker 2 Sounds like a terrible appetizer.

Speaker 1 Yeah, I personally cannot eat liver. I've operated on the liver too much.
Oh, God. One food I cannot do that.
No one wants organ on a chip. Yeah, organ on a chip.

Speaker 1 So in the lab, they grow these cells and then they introduce the drug.

Speaker 1 And you can actually see whether or not it injures the cells better than if you inject some bunny rabbit that you is not going to talk to you and say my liver hurts.

Speaker 1 So these new technologies have the promise of replacing some of this routine animal testing. You would cut six months out of that approval process.

Speaker 1 You lower R ⁇ D costs for pharma companies and inventors, which could lower drug prices for everyday Americans. And it reduces animal use.
There's too much animal use.

Speaker 2 Are there any other areas where AI can come and help as we move into the 21st century?

Speaker 1 Yeah, we're bringing in a team that is really exciting. They're going to use, introduce AI into the review process to help the reviewer, to make the reviewer's

Speaker 1 work stream much more streamlined. And summarize things.

Speaker 1 There are parts of the drug application that are so perfunctory, that are outdated, that could be streamlined, that could be abstracted with AI to help the reviewer.

Speaker 2 So here, like all other aspects of government that Trump is taking on, you're saying there's actually too much red tape and we're red taping the wrong things, it sounds like you're saying.

Speaker 1 Why does it take 10 years to bring a drug to market in the United States because of the regulatory steps? I mean, people are dying. People need cures and meaningful treatments.
And

Speaker 1 my predecessor in this role was focused, as he stated,

Speaker 1 his number one goal was fighting misinformation. Well, our number one goal is delivering cures and meaningful treatments and healthier foods for Americans.

Speaker 1 That is our focus. And so you've heard about consolidation or changes or cuts at the FDA.
Those were not cuts to scientists or reviewers or inspectors. Absolutely none.

Speaker 1 They were cuts to communications staff, FDA's lobbyists to Congress, and to the IT systems here where there's a lot of opportunity for efficiencies.

Speaker 2 Yes, there's been definitely there's been pushback on the number of people who were ousted.

Speaker 2 I think it was your predecessor who said the FDA, as we know it, is gone, that the experts are gone, people with decades of institutional knowledge have been turfed, suggesting there might now be a safety issue here.

Speaker 1 There is a massive growth of FDA employees under the Biden administration. And when the media reports that there were

Speaker 1 cuts, which

Speaker 1 many were early retirements, people who took early retirement, none were to scientific reviewers or inspectors or law enforcement at the FDA.

Speaker 1 They were to IT communications, legislative affairs. And so what you're not hearing in the mainstream media is that there was a 100% increase in the number of FDA employees since 2006.

Speaker 2 You have about 18,000 and it's been cut about 3,500 since you and Kennedy got here. So you're saying we had more like 9,000?

Speaker 1 We had 9,500 employees at the FDA in 2006. Oh, wow.
And so when you doubled.

Speaker 1 When you report that there were cuts and you don't report that there was a 100% increase in employees in the preceding years,

Speaker 1 that the number of employees doubled in the preceding years, that is misleading.

Speaker 2 And the people who we've gotten rid of, losing them is not going to slow down drug approval or safety procedures because they were, sounds like more administrative people.

Speaker 1 There were no cuts to scientists, reviewers, or inspectors or law enforcement. And my goal is to make sure that every one of those people has all the resources they need to do their job well.

Speaker 1 Now, cuts are never perfect. And so we have done an assessment.
And there are

Speaker 1 some individuals that we have invited back.

Speaker 1 There were a couple people who were taking the early retirement, and we were told of their sort of how well they performed here and we encouraged them to stay.

Speaker 1 But to not report that the agency has doubled since 2006 before this cut, in my opinion, is not telling the whole story.

Speaker 2 No, it's dishonest.

Speaker 1 It's dishonest.

Speaker 2 Is it swampy here? And by that I mean we had a report that when Secretary Kennedy came over and addressed the troops last Friday, some people got up and walked out.

Speaker 2 They were disgusted by him, which seems like a bad sign.

Speaker 1 Yeah, I was in that room. Nobody got up and walked out.
Now, we did stream it.

Speaker 1 So if somebody was watching it in their office and got up to go to the bathroom during the speech, maybe that constituted getting up and walking out. I don't know.

Speaker 1 I was in that room and there was incredible energy in that room because he talked about how agencies that are set up to defend public safety sometimes become captured by the organizations that they are set out to regulate.

Speaker 1 And he talked about the EPA has had a history where they have cycled and at times have been captured by the industry. And he encouraged people at the FDA to speak up, think independently, and that

Speaker 1 he had his full support behind them. So it was an incredible talk.
And of course, you're going to hear a clip or a phrase pulled out out of context. But I was in that room.
Nobody walked out.

Speaker 1 It was incredibly a strong message. The FDA is strong, and we're going to continue to be strong.
And that's because we believe in the scientists. How's your relationship with Bobby Kennedy? It's good.

Speaker 1 You know, I got to know him during the nomination process, and I found that he always listens to me.

Speaker 1 He values scientists on questions where he has, you know, some skepticism or he has some honest questions that he wants to pose. And I think that's what we need.

Speaker 1 I mean, first of all, he represents America.

Speaker 1 There are

Speaker 1 President Trump and Robert F. Kennedy Jr.
are the two most popular political people in the United States right now. That's polling day.
That's not my opinion. That's polling day.

Speaker 1 And he is, he represents the American people. He has questions.

Speaker 1 He wants the scientific process to run its course. And so he's posing the questions, and he values our opinion.
Everything I've put before him, he has valued my input on.

Speaker 1 And so we're going to see new studies come out. We're going to talk about chronic diseases.
We're going to look at food and food ingredients. And he's provided some really great leadership.

Speaker 1 I've enjoyed.

Speaker 2 Are we redoing the food pyramid?

Speaker 1 We're redoing the food pyramid. Thank God.

Speaker 1 And

Speaker 1 no longer are we going to say it's, you have to have these calories. It doesn't matter how you get them.
It doesn't matter if it's all ultra-processed foods. It's just pure calories in calories out.

Speaker 1 That dogma, which had no scientific support, was a massively underfunded endeavor. We let the industry tell us as a government.
what's healthy and what's not healthy.

Speaker 1 And even with the recent Biden administration suggestion to have front of package labeling, they picked sodium, saturated fat, and added sugar in there.

Speaker 1 I think they got maybe one thing right out of those four, but they ignored a giant sloth of food ingredients.

Speaker 1 And so when you ignore a thousand chemicals, some of which are petrochemicals that have been introduced into the food supply simply because the industry has self-deemed them as safe, when you ignore that, then you can't call something healthy just because it it has a low amount of saturated fat.

Speaker 1 I mean, that's old dogma.

Speaker 2 Talk about part of the story. Are you a yo-yo dieter? You diet, lose weight, and you gain it all back plus a few, and then later you lose it again, and so on and so forth.
That can be dangerous.

Speaker 2 Studies show this could actually increase health problems. Breaking free of your yo-yo diet pattern is why doctors created lean.
Lean is a supplement and you don't need a prescription.

Speaker 2 Lean includes natural ingredients targeting weight loss in three powerful ways. Maintaining healthy blood sugar, controlling appetite and cravings, and it helps burn fat by converting fat into energy.

Speaker 2 Listen, if you're tired of losing weight and gaining it back and you want to lose meaningful weight at a healthy pace, lean could be something for you to consider.

Speaker 2 Let me get you started with 20% off when you enter MK20 at takelean.com. That's mk20 at takelean.com.

Speaker 9 Why did we build the first American nuclear plant in 30 years? Because we're leading the way to secure American energy dominance.

Speaker 9 And why announce over $70 billion in energy infrastructure investments to keep meeting America's energy demand, win the AI race, and because our 9 million customers deserve affordable, reliable energy to power their homes and businesses.

Speaker 9 At Southern Company, the investments we make today are powering America's energy future.

Speaker 5 Hey guys, Joel Kimbooster here here with a very exciting announcement that I am the newest host of the podcast Bad Dates.

Speaker 5 I am so excited to be here and sharing all the wildest, most chaotic, and iconic Bad Date stories with you.

Speaker 5 I'll be joined by friends like Peppermint, Scott Thompson, Casey Wilson, Ron Funches, and MJ Rodriguez, and we'll hear all about their most notorious bad dates.

Speaker 5 It'll make you laugh, cry, cringe, and maybe make you feel a little better about your own dating life. You don't want to miss it.

Speaker 5 Listen to bad dates by subscribing to SiriusXM Podcast Plus on Apple Podcasts or listening wherever you get your podcasts.

Speaker 2 Secretary Kennedy said this week that we are going to know what causes autism by September. Is that crazy talk?

Speaker 1 No, people want to know a lot of parents have been dealing with kids with autism. I mean, one in 32 kids in America today have autism.
We can't just keep medicating every kid with.

Speaker 2 It was one in 10,000 in the 90s.

Speaker 1 It was unheard of. And the sort of repetitive motions, the ticks, the heavy, the complete nonverbal child.
Where did you see that in the 1940s and 50s? And so we have to look at everything.

Speaker 1 And when you do science, you can't say, hey, we're going to do a study of what is causing this epidemic affecting one in 32 kids. But you can't look at

Speaker 1 these these potential causes.

Speaker 2 That's not how science is. That's what we've been saying.

Speaker 2 And for the record, you're not saying it, but people are talking in part about vaccines because Kennedy has said it should be on the list of things we look at.

Speaker 2 Now, his critics will say, he's blaming it all on the vaccine. He's blaming autism on the vaccine.
I've talked to him personally. That's not what he says.
That's not what he's saying.

Speaker 2 He says they're growing up in a toxic stew. That's one of the many things.
And in particular, like the aluminum that they put in it as a preservative.

Speaker 2 Like we should be looking at everything they're consuming and we're forcing on them.

Speaker 1 I don't know what causes autism, but I'm deeply concerned about the rise. If I had to make a hypothesis as a scientist, not as a regulator, but as a scientist, and Dr.

Speaker 1 Bauchari is going to be launching a very impressive study using electronic health big data that we're helping curate.

Speaker 1 I think it is the cumulative burden of all of these exposures, environmental and dietary, that alter the microbiome.

Speaker 1 Remember, 90% of the of the serotonin made, which is involved in mood and mental health, is from bacteria in the microbiome. That's where it's produced.

Speaker 1 And when you mess up the microbiome, when you carpet bomb the microbiome with all of these ingredients that don't appear in nature, these are novel chemicals. What are we doing?

Speaker 1 So we've known for a long time as a scientific community that kids with autism have different stool composition, different biodiversity.

Speaker 1 So when you look at the billion different bacteria that live in the microbiome, there may be an association between change of the microbiome and autism and things that are changing the microbiome that we've not yet fully appreciated.

Speaker 1 And that could be a whole list of things.

Speaker 2 I've heard you talk many times with me and others about,

Speaker 2 and this stuck out to me because I had C-sections, but about how vaginal births are in some ways much better for the baby because it will help their microbiome.

Speaker 2 Like going through the birth canal is very helpful to a baby's microbiome.

Speaker 2 But I was thinking about this because what we we have now is a scenario in which C-sections are routinely pushed on mothers because it's easier for the OBGYN.

Speaker 2 They can schedule their life more easily. The nursing staff supports it.
They can get a wink or two, whereas the vaginal birth is a different story, natural, whatever.

Speaker 2 So the kid comes out without that advantage. Then we're very quick to prescribe antibiotics for young kids.

Speaker 1 Carpet bombing the microbiome.

Speaker 2 Over and over, even when they're little. We're not setting them up for success.
Then we fill them full of processed foods.

Speaker 2 Or maybe we give them infant formula that's riddled with processed or seed oils or added sugars that don't need to be there.

Speaker 2 And then we, for a long time, didn't expose them to peanuts or other potential allergens, which made them weaker and more susceptible to these allergies.

Speaker 2 And then, you know, there's all these antibiotics in foods and estrogen-altering chemicals in foods. And now the child is basically hobbled in a lot of ways through absolutely no fault of their own.

Speaker 2 And really the parents either. The parents wouldn't have necessarily known not to do the, your kid has strep, your doctor says give them antibiotics, you do it.

Speaker 2 And then on top of that, we've got all these vaccines and we've got all these processed foods and we've got all this weird stuff and you know your cow milk and

Speaker 2 it's so much.

Speaker 2 And so it's almost like the system is set up to get your kids sick. And then we say, why is everybody getting colon cancer before they turn 25?

Speaker 1 Right?

Speaker 2 So no one's even taking a hard look at that. Now it seems like for the first time we have a team that's saying, no, we're taking a hard look at all of that.

Speaker 1 All of it. We have to look at all of it.

Speaker 1 I mean, if you look at how much children are suffering, they're in pain, they're depressed, they're dealing with injecting themselves with insulin, something you would rarely see a kid have type 2 diabetes in their teenage years a generation ago.

Speaker 1 Now you got 20% of kids who have diabetes or pre-diabetes. The vast majority are type 2 diabetes, right?

Speaker 1 We have only been talking about treating the rise in colon cancer in young people with new chemotherapy. New chemotherapy is not going to address the root causes.

Speaker 1 We need to do it, and we want to see new drugs come to market quickly, but we've got to talk about what is insulting the microbiome, driving general body inflammation.

Speaker 1 We've got to talk about the two underlying causes of so many chronic diseases, in my opinion, insulin resistance and general body inflammation. And it's all the stuff that we put down.

Speaker 1 The body's immune system is reacting and causing some inflammation so we're not just going to be looking at new chemo for colon cancer we're going to be focused on healthy food at the fda and we're looking at a school lunch grant program that's school for schools that want to convert to healthier foods but don't know how and they need help we want to help them is guidance coming out for parents on how to feed their child in a healthy way.

Speaker 2 Whether it, you know, saying this to you before we got started, the American breakfast right now is, you know, especially for kids, cereal, bagels, English muffins, toast, French toast.

Speaker 2 It's all carbs, Danish, right?

Speaker 1 It's all, all starchy carbs.

Speaker 2 Then God knows what they get at school for lunch. And even when you make them lunch, it's hard.
You don't know what it's like. Chicken fingers, good or bad? Fried, better than lunch meat? Probably.

Speaker 2 Well, what? Like, people don't know. They don't know.
They've had no real guidance. Are they going to get some?

Speaker 1 So we are redoing the food pyramid, but

Speaker 1 this is like the number one issue right now in health in America is people don't know how to switch to healthier foods, right? And I wish, you know, there's zealots in every aspect of healthcare.

Speaker 1 And you hear them, you know, the media gives them a lot of airtime and their issues are legitimate oftentimes.

Speaker 1 But I often look at these zealots and I say, I wish you would take 10% of your enthusiasm over this little issue in healthcare and actually talk about school lunches and healthy foods and educating parents on what to

Speaker 1 feed their children and

Speaker 1 sugary drinks that are ubiquitous and microplastics and seed oils and chemicals and the grass and all of it, all of it.

Speaker 1 So we're going to see some guidance come out that I think is going to be helpful.

Speaker 1 Schools that want to convert to healthier, more organic, more local and possible foods, don't know how, and they got limited budgets. That's where we can provide some assistance.

Speaker 1 So, on a pilot basis for schools that want to convert and don't know how, we're going to help them get off the cupcakes. I didn't realize how many schools feed breakfast to children, donuts, cupcakes,

Speaker 1 ding-dongs,

Speaker 1 French toast, as if it alludes to the French. Right, so it's more sophisticated.
Right, more sophisticated, right?

Speaker 1 So, this is where the entire medical establishment can pivot and focus on. And you're going to see grants coming out of the NIH.
We're working in coordination

Speaker 1 with the NIH to make sure there's research in this area. You know, the NIH has really focused on genetics.

Speaker 1 And the entire culture of the NIH and thus the entire academic medical community in the United States has been a culture focused on the genome.

Speaker 1 based on the Francis Collins era that the gene is responsible for most of our health problems and the gene can solve most of our health problems.

Speaker 1 And you look at the NIH, individual institutes within the National Institutes of Health, and it's geneticists all over the place.

Speaker 1 You look at the Institute for Child Health at the NIH, and it's run by a geneticist who parades around

Speaker 1 finding a gene involved in some ultra-rare gene disorder. That's good and it's important, but nobody is talking about the food our kids are eating.

Speaker 2 By the way, there's not much we can do about our genes.

Speaker 1 The genes are not the problem of our, not the cause of our chronic disease epidemic. It's what we're doing or what is being done to children by adults today, unknowingly, with good intentions.

Speaker 1 Sometimes, you go to the National Institute of Environmental Health at the NIH, go to the website, and you'll see the director has on there that they were involved in identifying a gene that may be associated with obesity.

Speaker 1 What are you doing? I mean, there's value in that research.

Speaker 1 How about the ding-dongs and cupcakes and donuts and French toasts that the kids are eating with government tax dollars every morning at school and nobody seems to be.

Speaker 2 And I've heard you say before, if you fix your microbiome, you actually might be less hungry, less prone to obesity. Like the things you were talking about are all to set people up for a...

Speaker 2 a healthier lifestyle that's a little easier.

Speaker 2 You know, that they may be victims to cravings that were created by this terrible food pyramid and them following the American diet that shoved down our throat.

Speaker 1 Yeah, look, as a surgeon, I met patients that would do everything to lose weight. They did all the right things.
They switched to better foods and they would exercise. They couldn't lose weight.

Speaker 1 What was happening there? Can we learn from those individual patients? Maybe the microbiome was altered in a way that is not easy to fix by just switching back.

Speaker 1 Maybe all of those years, the cumulative insult to the microbiome was altered. Now, there are some researchers doing this.
I met the microbiome researcher at the NIH, and it's like a tiny shop.

Speaker 1 Like this should be the main focus. Yes.
You know, the NIH has collected DNA, all the DNA information on 1.2 million Americans. And you'll say, I didn't know about this.
What, you know,

Speaker 1 what, why?

Speaker 1 They have been doing it for the last six or seven years in search of a genetic basis for health disparities. And that entirely...

Speaker 1 What does that mean? It means they want to understand why certain populations have more chronic diseases than others. And they believe that it's in the genome.

Speaker 1 And so they collected this giant genetic library. They would pay Americans, say, $25.

Speaker 1 80% are African-American, Latino, or transgender,

Speaker 1 because they want to unlock why they have different rates of chronic diseases. They have this massive library.
When Jay Bhattacharya came into office, the...

Speaker 1 previous director moved that entire database project to another office outside of the director's office. Maybe so he wouldn't touch it.
Interesting. And what are they doing?

Speaker 1 Like, I'm not saying there's no value in that, but you're not, you can't even tell us how to lose weight. You can't even tell us how to, what foods are healthy for children.

Speaker 1 You can't even tell us about seed oils or food dyes or ingredients that are added just for shelf life. And so that has been the entire culture of the medical establishment.

Speaker 1 And when they launched that project, they went to the oldest African-American church in Harlem. They went to Atlanta, Detroit, and they recruited people from minority communities.

Speaker 1 And they told them, no longer is

Speaker 1 our medical recommendations going to be blanket. They are going to be custom-tailored to

Speaker 1 your

Speaker 1 population.

Speaker 2 Good luck doing that with trans people.

Speaker 2 Okay, a couple of quick things.

Speaker 2 One of your predecessors here has said you're going to have to to expect massive pushback on all of this.

Speaker 2 Like it might be too high in the sky that, for example, if we remove all ultra-processed foods from school lunch programs, we might bankrupt a bunch of farmers. Like,

Speaker 2 are we too optimistic? You know,

Speaker 2 is the moonshot not possible?

Speaker 1 I think people are now discovering that they've been duped. with an industry that has told them, don't worry, all this food is healthy for kids.
It's low in calories. It has low fat.

Speaker 1 So, you know, go ahead and it's fine. That's sort of the between the lines message.

Speaker 1 And I think they're very suspicious and they want to find an ingredient that accounts for the chronic disease epidemic. I don't believe there's any single ingredient.

Speaker 1 I think it's the entire gamut of less exercise, food chemicals, not eating the right foods, micronutrient poor foods. We have foods now in the United States that are basically

Speaker 1 grown with caffeine, you know, potassium, phosphorus, nitrogen in the roots. And there's no nutrients.

Speaker 1 You know, there's a deficiency of good soil. And so you get micronutrient deficient food.
And you can eat a lot, but your satiety, that is your sense of feeling full,

Speaker 1 is not triggered because you're not getting those nutrients.

Speaker 1 And so what you do is you have this weird feeling after you eat where you're kind of full and bloated, but you're still hungry. And some of those chemicals make you more hungry.

Speaker 1 The food industry, they're not bad people. They're actually good people.
They've done what

Speaker 1 we as a society have asked them to do, and that is focus on food insecurity and mass production.

Speaker 1 Now, however, seeing that these chronic diseases have skyrocketed in our country, in our generation, we've got to take a step back and ask, how can we get healthier foods out there?

Speaker 2 And I wanted to go back to the animal testing because this is something near and dear to my heart. I'm a big animal rights person.

Speaker 2 I do eat meat and animal products and I get letters from PETA all the time. But the animal testing is a heartbreaker and that what Fauci was doing to the beagles is really deeply disturbing.

Speaker 2 And what I didn't, I never realized until you just said it right now, it's because they're compliant, which is just so sad. It's sad.
So how do you stop that?

Speaker 2 Can we as humans stay safe in the drugs we consume and the products we consume without torturing sweet little beagles.

Speaker 2 And I will throw in a word for the bunnies and even the little lab rats, which, you know, animal torture just seems beneath us at this point in our evolution, but you tell me.

Speaker 1 God did not make these animals on planet Earth for us to do cruel things to them and subjugate them.

Speaker 1 It does not seem right. And so we are doing everything we can, and we're taking a lot of steps to reduce animal testing requirements and to stop unnecessary animal testing.

Speaker 1 A single monoclonal antibody that was

Speaker 1 developed for approval used 144 chimpanzees in the animal testing requirement. What are we doing? And these chimpanzees are not, you know, living with great sunlight and eating bananas.
It's not,

Speaker 1 you know, there is

Speaker 1 a problem here. And when you

Speaker 1 realize that the computational models can do as good or better of a job in predicting when the lab-based organ cells tested or something called organoids where you can actually grow an organ in a lab and it's not a functional organ but it has the properties of those cells and you can test liver toxicity or heart toxicity or myocarditis.

Speaker 1 Those models should be replacing animal testing. So the first announcement we had when I came in as commissioner was to take steps to reduce unnecessary animal testing.

Speaker 2 Reduced by a lot?

Speaker 2 almost entirely with a goal toward hitting

Speaker 2 entirely or what?

Speaker 1 I'd like to see as as much reduction of unnecessary animal testing as humanly possible. Look, as a surgeon, we had pig labs

Speaker 1 at Johns Hopkins where the students and residents would learn how to do surgery on the pigs. I personally believed it had no impact on learning.
They could have learned

Speaker 1 from simulations, computerized simulations. They can learn from watching us in the operating room.
It provided no add-its because they were unnecessary.

Speaker 1 And every week or so, they would have pigs anesthetized. It was big production.
It was expensive. And in my opinion, it was unnecessary.
We've got to modernize. Okay.

Speaker 2 So last but not least, 3,500 gone in cooperation with Doge. Will there be more cuts?

Speaker 1 There are no plans for any mass cuts. Now, if somebody has not logged onto their VPN in two years, we don't want them working.

Speaker 1 If somebody's doing an incredible job, and we measure performance down to 15 minute increments with reviewers that are doing scientific reviews. The reviews are highly tracked.

Speaker 1 And so if somebody's doing a good job doing that review, we want to encourage them and support. It's hard work.
Doing the reviews is hard work.

Speaker 1 And so we want to do other things here at the FDA to support a great culture. scientific forums, speakers, roundtables.
We want to encourage them to spend some of their time doing creative work.

Speaker 1 And so we're doing a lot right now to create more of a teamwork culture and less of an individual siloed culture that is the culture that I walked into.

Speaker 2 It feels like you really want to make this a better place for people to work, more collegial, more of a feeling of camaraderie, a shared mission. Is it possible?

Speaker 2 You know, there are certain government agencies, I'm just going to say it, where they're hard left.

Speaker 2 They can't stand Trump, and there will be a natural resistance to his appointees trying to do anything to their agency.

Speaker 1 There are some of those folks here, but you know, they're all God's children, and I hope to work with all of them. So, you know, that's my job as a leader to try to win their confidence.

Speaker 1 And I hope to do it by upholding my mission to

Speaker 1 put out their gold standard science and common sense together. We can do both.
Healthier food for children.

Speaker 1 rebuilding the public trust and focusing not on the peripheral distractions, but focusing on cures and meaningful treatments for Americans.

Speaker 2 And when this is done,

Speaker 2 is there a chance you're going to a drug company?

Speaker 1 Zero chance.

Speaker 1 In terms of if there's an inventor that I might have the chance with to work with, I have no idea. When it comes to the large pharmaceutical companies,

Speaker 1 you will not, I'm not auditioning for a job with them. At the same time, I love them.

Speaker 1 I believe in love thy neighbor, and I hope we can work with them to create a great user-friendly process to chop down that 10-year timeframe to an approval to a much shorter timeframe.

Speaker 1 And I'm committed to work with them to get that down.

Speaker 2 I can't wait to see what you do. Thank you so much.
Thank you, Megan. Thanks for being willing to do the job.

Speaker 1 Thanks for being a champion for my mom's.

Speaker 1 My pleasure.

Speaker 2 Ah, so interesting. I love him.
I feel so much better that he's here, right? I feel like we're in good hands. He's got his work cut out for him.
And we'll stay tuned.

Speaker 2 We'll keep you updated on what happens over here. Now, in the meantime, I have got to tell you something important before we go.

Speaker 1 Okay.

Speaker 2 Everyone loves when Maureen Callahan comes on, including me.

Speaker 2 And I told you the last time she came on that we were going to do, we did this long debrief on the Megan Markle ridiculousness that on Netflix, her show,

Speaker 2 you know, showing you really tough things like how to dump pretzels into a bag. That's her new show.

Speaker 1 Well,

Speaker 2 we had this idea.

Speaker 1 to do our own version of her show with love.

Speaker 2 I had a naughty word that I was going to use instead, but no,

Speaker 2 we've done it, is my point.

Speaker 2 Maureen and I have shot our own series, and she's going to be on the show tomorrow with the presentation of what we came up with, which I think you're really going to enjoy.

Speaker 2 Here's just a little sneak peek.

Speaker 2 It's important to me to stay relatable.

Speaker 2 I love to elevate a guest's visit.

Speaker 1 Microwave popcorn. You plop it right in there.

Speaker 2 It's so simple. Only the lazy people don't do this.

Speaker 3 Put it in a paper bag.

Speaker 1 Here we go. It's right behind you.
Oh my God.

Speaker 1 You did it.

Speaker 2 We're going to put it in one of these special cellophane bags.

Speaker 1 Oh!

Speaker 2 It's okay, these aren't, it's not expensive like your clothes are.

Speaker 1 Look at how fun that is.

Speaker 2 These are amazing and you're going to absolutely love them. This we're just gonna put into a different.

Speaker 2 They're spectacular. And then I just, and then I just dump them.

Speaker 1 Just like that.

Speaker 2 Where are you getting all these like mini brainstorms? What's like, I'm so impressed. Maybe in the next wave of our friendship, I'll try to explain it to you.

Speaker 2 I died. When I saw the first clip, I mean, it's a longer one than what you just saw there.
I was with Abby. We cried.
We were laughing so hard.

Speaker 2 I think you guys are going to love tomorrow's show, and I can't wait to bring it to you. So we'll see you then.

Speaker 2 Thanks for listening to the Megan Kelly Show. No BS, no agenda, and no fear.

Speaker 2 The human body is incredible, capable of repair and growth that amazes scientists even in 2025. But as the years pass, natural healing and building processes slow down.

Speaker 2 While this is normal, there is a way to support your body. A collagen supplement from Ancient Nutrition can help you look and feel your best.

Speaker 2 For centuries, people have searched for a mythical fountain of youth. Spoiler alert, it doesn't exist.
However, collagen is a proven way to promote youthful health and appearance.

Speaker 2 And this is why I want to tell you about Ancient Nutrition's Multi-Collagen multi-collagen advanced lean.

Speaker 2 Ancient Nutrition combines ancient wisdom with modern science to create high-quality supplements. It's delicious and easy to incorporate into daily routines.

Speaker 2 You can mix it right into coffee, matcha, or your smoothie. Right now, enjoy 25% off your first order at ancientnutrition.com/slash Megan.
That's ancientnutrition.com/slash Megan for 25% off.

Speaker 2 Support your bod and feel your best with ancient nutrition.

Speaker 3 Hey, weirdos.

Speaker 4 I'm Elena, and I'm Ash, and we are the host of Morbid Podcast.

Speaker 3 Each week, we dive into the dark and fascinating world of true crime, spooky history, and the unexplained.

Speaker 4 From infamous killers and unsolved mysteries to haunted places and strange legends, we cover it all with research, empathy, humor, and a few creative expletives.

Speaker 3 It's smart, it's spooky, and it's just the right amount of weird.

Speaker 4 Two new episodes drop every week, and there's even a bonus once a month.

Speaker 3 Find us wherever you listen to podcasts.

Speaker 5 Yay! Woo! Aye!

Speaker 5 If you're a smoker or dipper ready to make a change, you really only need one good reason. But with Zen nicotine pouches, you'll discover many good reasons.

Speaker 5 Zen is America's number one nicotine pouch brand. Plus, Zen offers a robust rewards program.
There are lots of options when it comes to nicotine satisfaction, but there's only one Zin.

Speaker 5 Check out Zinn.com/slash find to find Zin at a store near you.

Speaker 5 Warning, this product contains nicotine. Nicotine is an addictive chemical.